Barclays PLC 13D and 13G filings for Ironwood Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-12 3:34 pm Sale | 2025-09-30 | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | Barclays PLC | 3,167,713 1.950% | -7,966,144 (-71.55%) | Filing |
| 2025-08-12 5:58 pm Purchase | 2025-06-30 | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | Barclays PLC | 11,133,857 6.880% | 11,133,857 (New Position) | Filing |